Expertise in
1
conditions

Jun X. Bai

No. 126 Yanta Road, 
Xi'an, CN 
Expertise in
1
conditions
No. 126 Yanta Road, 
Xi'an, CN 

Overview

Jun Bai practices practicing medicine in Xi'an, China.

Mr. Bai is highly rated in 1 condition, according to our data. His clinical expertise encompasses Lung Adenocarcinoma, Triple-Negative Breast Cancer, Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC).

He is actively involved in clinical research, co-authoring 57 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

No. 126 Yanta Road, Xi'an, 710054, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multicenter, Randomized, Open-label, 2-arm, Phase II Study With a Safety lead-in Phase Evaluating the Combination of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or Infusional 5-fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab in Chinese Patients With BRAF V600E Mutant Metastatic Colorectal Cancer.
A Multicenter, Randomized, Open-label, 2-arm, Phase II Study With a Safety lead-in Phase Evaluating the Combination of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or Infusional 5-fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab in Chinese Patients With BRAF V600E Mutant Metastatic Colorectal Cancer.
Enrollment Status: Completed
Publish Date: April 30, 2026
Intervention Type: Drug
Study Phase: Phase 2

57 Total Publications

A CAR-T Tonic Signaling Code Predicts Anti-Tumor Efficacy in Diffuse Midline Glioma.
A CAR-T Tonic Signaling Code Predicts Anti-Tumor Efficacy in Diffuse Midline Glioma.
Journal: Neuro-oncology
Published: January 08, 2026

Frequently Asked Questions about Jun X. Bai

Is Jun X. Bai a top-rated expert for Lung Adenocarcinoma?

MediFind is an objective health platform that identifies experts based on real-world data. Jun X. Bai is classified as an Advanced expert for Lung Adenocarcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jun X. Bai participate in research or clinical trials?

Yes. Jun X. Bai has published 57 articles and abstracts on conditions like Lung Adenocarcinoma. You can view a list of Jun X. Bai's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Bai's expertise for a condition
ConditionClose
      View All 9 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile